Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Sotera Health (SHC) Interest & Investment Income (2020 - 2026)

Sotera Health has reported Interest & Investment Income over the past 6 years, most recently at -$35.0 million for Q4 2025.

  • For Q4 2025, Interest & Investment Income rose 14.43% year-over-year to -$35.0 million; the TTM value through Dec 2025 reached -$155.7 million, up 5.45%, while the annual FY2025 figure was -$155.7 million, 5.45% up from the prior year.
  • Interest & Investment Income for Q4 2025 was -$35.0 million at Sotera Health, up from -$39.1 million in the prior quarter.
  • Over five years, Interest & Investment Income peaked at -$10.4 million in Q1 2022 and troughed at -$42.7 million in Q4 2023.
  • A 5-year average of -$30.9 million and a median of -$33.7 million in 2022 define the central range for Interest & Investment Income.
  • Biggest five-year swings in Interest & Investment Income: surged 67.56% in 2021 and later tumbled 177.49% in 2023.
  • Year by year, Interest & Investment Income stood at -$15.6 million in 2021, then plummeted by 106.76% to -$32.3 million in 2022, then plummeted by 32.18% to -$42.7 million in 2023, then rose by 3.97% to -$41.0 million in 2024, then grew by 14.43% to -$35.0 million in 2025.
  • Business Quant data shows Interest & Investment Income for SHC at -$35.0 million in Q4 2025, -$39.1 million in Q3 2025, and -$40.7 million in Q2 2025.